These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 10529267

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E.
    Veinbergs I, Van Uden E, Mallory M, Alford M, McGiffert C, DeTeresa R, Orlando R, Masliah E.
    Exp Neurol; 2001 Jul; 170(1):15-26. PubMed ID: 11421580
    [Abstract] [Full Text] [Related]

  • 3. An extrahepatic receptor-associated protein-sensitive mechanism is involved in the metabolism of triglyceride-rich lipoproteins.
    van Vlijmen BJ, Rohlmann A, Page ST, Bensadoun A, Bos IS, van Berkel TJ, Havekes LM, Herz J.
    J Biol Chem; 1999 Dec 03; 274(49):35219-26. PubMed ID: 10575007
    [Abstract] [Full Text] [Related]

  • 4. [Expression profiles of lipid metabolism-related genes in liver of apoE(-/-)/LDLR(-/-) mice].
    Du HQ, Yin M, Ye HY, Shang YJ, Dai XD, Jing W, Zhang L, Xiao N, Li JF, Pan J.
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov 03; 36(11):751-5. PubMed ID: 18307880
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intracellular localization and metabolism of chylomicron remnants in the livers of low density lipoprotein receptor-deficient mice and apoE-deficient mice. Evidence for slow metabolism via an alternative apoE-dependent pathway.
    Mortimer BC, Beveridge DJ, Martins IJ, Redgrave TG.
    J Biol Chem; 1995 Dec 01; 270(48):28767-76. PubMed ID: 7499399
    [Abstract] [Full Text] [Related]

  • 8. Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor.
    Linton MF, Hasty AH, Babaev VR, Fazio S.
    J Clin Invest; 1998 Apr 15; 101(8):1726-36. PubMed ID: 9541504
    [Abstract] [Full Text] [Related]

  • 9. Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol.
    Espirito Santo SM, Pires NM, Boesten LS, Gerritsen G, Bovenschen N, van Dijk KW, Jukema JW, Princen HM, Bensadoun A, Li WP, Herz J, Havekes LM, van Vlijmen BJ.
    Blood; 2004 May 15; 103(10):3777-82. PubMed ID: 14739216
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of low density lipoprotein receptor eliminates apolipoprotein B100-containing lipoproteins from circulation and markedly prevents early atherogenesis in apolipoprotein E-deficient mice.
    Murayama T, Yokode M, Horiuchi H, Yoshida H, Sano H, Kita T.
    Atherosclerosis; 2000 Dec 15; 153(2):295-302. PubMed ID: 11164418
    [Abstract] [Full Text] [Related]

  • 11. Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double knockout mice.
    Hu L, Boesten LS, May P, Herz J, Bovenschen N, Huisman MV, Berbée JF, Havekes LM, van Vlijmen BJ, Tamsma JT.
    Arterioscler Thromb Vasc Biol; 2006 Dec 15; 26(12):2710-5. PubMed ID: 17038633
    [Abstract] [Full Text] [Related]

  • 12. Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Sberna AL, Assem M, Xiao R, Ayers S, Gautier T, Guiu B, Deckert V, Chevriaux A, Grober J, Le Guern N, Pais de Barros JP, Moore DD, Lagrost L, Masson D.
    Arterioscler Thromb Vasc Biol; 2011 Oct 15; 31(10):2232-9. PubMed ID: 21778422
    [Abstract] [Full Text] [Related]

  • 13. Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.
    Véniant MM, Zlot CH, Walzem RL, Pierotti V, Driscoll R, Dichek D, Herz J, Young SG.
    J Clin Invest; 1998 Oct 15; 102(8):1559-68. PubMed ID: 9788969
    [Abstract] [Full Text] [Related]

  • 14. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins.
    Ishibashi S, Herz J, Maeda N, Goldstein JL, Brown MS.
    Proc Natl Acad Sci U S A; 1994 May 10; 91(10):4431-5. PubMed ID: 8183926
    [Abstract] [Full Text] [Related]

  • 15. In the absence of endogenous mouse apolipoprotein E, apolipoprotein E*2(Arg-158 --> Cys) transgenic mice develop more severe hyperlipoproteinemia than apolipoprotein E*3-Leiden transgenic mice.
    van Vlijmen BJ, van Dijk KW, van't Hof HB, van Gorp PJ, van der Zee A, van der Boom H, Breuer ML, Hofker MH, Havekes LM.
    J Biol Chem; 1996 Nov 29; 271(48):30595-602. PubMed ID: 8940032
    [Abstract] [Full Text] [Related]

  • 16. Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice.
    Karavia EA, Papachristou DJ, Kotsikogianni I, Giopanou I, Kypreos KE.
    FEBS J; 2011 Sep 29; 278(17):3119-29. PubMed ID: 21740524
    [Abstract] [Full Text] [Related]

  • 17. Rapid initial removal of chylomicron remnants by the mouse liver does not require hepatically localized apolipoprotein E.
    Yu KC, Jiang Y, Chen W, Cooper AD.
    J Lipid Res; 2000 Nov 29; 41(11):1715-27. PubMed ID: 11060341
    [Abstract] [Full Text] [Related]

  • 18. Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice.
    Zsigmond E, Kobayashi K, Tzung KW, Li L, Fuke Y, Chan L.
    Hum Gene Ther; 1997 Nov 01; 8(16):1921-33. PubMed ID: 9382958
    [Abstract] [Full Text] [Related]

  • 19. RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors.
    Willnow TE, Rohlmann A, Horton J, Otani H, Braun JR, Hammer RE, Herz J.
    EMBO J; 1996 Jun 03; 15(11):2632-9. PubMed ID: 8654360
    [Abstract] [Full Text] [Related]

  • 20. Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice.
    van der Hoogt CC, Berbée JF, Espirito Santo SM, Gerritsen G, Krom YD, van der Zee A, Havekes LM, van Dijk KW, Rensen PC.
    Biochim Biophys Acta; 2006 Feb 03; 1761(2):213-20. PubMed ID: 16478678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.